(Q36814324)

16 August 2017

1 reference

title

Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer (English)

1 reference

16 August 2017

1 reference

Galvão DA

1

1 reference

16 August 2017

Taaffe DR

series ordinal

2

1 reference

16 August 2017

Spry N

series ordinal

3

1 reference

16 August 2017

Newton RU

series ordinal

4

1 reference

16 August 2017

publication date

8 May 2007

1 reference

Prostate Cancer and Prostatic Diseases

16 August 2017

published in

1 reference

16 August 2017

volume

10

1 reference

16 August 2017

issue

4

1 reference

16 August 2017

page(s)

340-346

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500975

16 August 2017

exact match

0 references

cites work

Prostate specific antigen only progression of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

Intermittent androgen deprivation therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

Review of exercise intervention studies in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

Exercise in Cancer Survivors: An Overview of Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

Resistance Exercise in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

Safety and efficacy of weight training in recent breast cancer survivors to alter body composition, insulin, and insulin-like growth factor axis proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

Evaluating the use of early hormonal therapy in patients with localised or locally advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

Promoting general health during androgen deprivation therapy (ADT): a rapid 10-step review for your patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

Changes in body composition during androgen deprivation therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

Low bone density and high percentage of body fat among men who were treated with androgen deprivation therapy for prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

Long-term effects of androgen deprivation therapy in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

Androgen deprivation therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

Bone loss and the evolving role of bisphosphonate therapy in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

Sex hormones and cognitive function in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

Increased incidence of diagnosed depressive illness in hypogonadal older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

Basal concentrations and acute responses of serum hormones andstrength development during heavy resistance training in middle-aged andelderly men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

Intermittent androgen suppression for locally advanced and metastatic prostate cancer: preliminary report of a prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

Once-weekly resistance exercise improves muscle strength and neuromuscular performance in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

Resistance Training and Reduction of Treatment Side Effects in Prostate Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

7 January 2021

Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

7 January 2021

Comparing treatments for localized prostate cancer--persisting uncertainty

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

7 January 2021

Resistance exercise dosage in older adults: single- versus multiset effects on physical performance and body composition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

7 January 2021

Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

7 January 2021

Risk of fracture after androgen deprivation for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

7 January 2021

Age differences in knee extension power, contractile velocity, and fatigability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

7 January 2021

Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

7 January 2021

Quality of life in prostate cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

7 January 2021

Anabolic responses to resistance training in older men and women: a brief review.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

7 January 2021

Effects of heavy-resistance training on hormonal response patterns in younger vs. older men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

7 January 2021

Comparative effects of high- and low-intensity resistance training on thigh muscle strength, fiber area, and tissue composition in elderly women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500975

7 January 2021

Identifiers

DOI

10.1038/SJ.PCAN.4500975

1 reference

Dimensions Publication ID

16 August 2017

1001697974

0 references

1 reference